Literature DB >> 7408394

Digoxin "receptors" in neonates: an explanation of less sensitivity to digoxin than in adults.

M Kearin, J G Kelly, K O'Malley.   

Abstract

To investigate the possibility of altered digoxin receptor binding properties in neonates, we compared digoxin binding with erythrocytes from neonates and adults. Neonatal erythrocytes had two and a half times as many digoxin binding sites as adult erythrocytes. The neonatal "receptors" also had dissociation constants for digoxin that were twice the adult value. These findings suggest that differences in binding properties may explain the clinical observation of decreased sensitivity to digoxin in neonates and infants.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7408394     DOI: 10.1038/clpt.1980.172

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  6 in total

Review 1.  Understanding developmental pharmacodynamics: importance for drug development and clinical practice.

Authors:  Hussain Mulla
Journal:  Paediatr Drugs       Date:  2010-08-01       Impact factor: 3.022

2.  Therapeutic drug monitoring.

Authors:  N Buchanan
Journal:  Indian J Pediatr       Date:  1986 Mar-Apr       Impact factor: 1.967

Review 3.  Indications for the measurement of plasma digoxin concentrations.

Authors:  J K Aronson
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

4.  The effect of digoxin on 86rubidium uptake by erythrocytes from mothers and babies.

Authors:  J G Kelly; R M McMillen; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1983-01       Impact factor: 4.335

Review 5.  Age-related differences in digoxin toxicity and its treatment.

Authors:  T G Wells; R A Young; G L Kearns
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

6.  Single daily dose of digoxin for maintenance therapy of infants and children with cardiac disease: is it reliable?

Authors:  M Bakir; A Bilgiç
Journal:  Pediatr Cardiol       Date:  1994 Sep-Oct       Impact factor: 1.655

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.